APLM · Apollomics Inc.
$23.40
+6.03 (+34.72%)
At close · Aug 14
Market Cap
$51.39M
Shares
2.20M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.40
Open$17.74
Day$17.28–24.00
52W close$3.93–36.65
Avg vol 30d36K
Short int7K · 0.3% float · 1.0d
Short vol53%
Last earningsDec 31, 2023
DataNov 2024–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Nov 25, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Strong Buy
Momentum
Strong
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+34%
above
Price vs 50-day avg
+31%
above
RSI (14)
68
neutral
MACD trend
Positive
52-week position
60%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+16%
trailing
YTD return
+25%
this year
Relative strength
+2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+275% holders QoQ · +12 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.31% of float · ▼ -32.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Squeeze score
35
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
162%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
7.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+34%
Bullish
Price vs 50-day avg
+31%
Bullish
RSI (14)
68
Neutral
MACD trend
Positive
Bullish
52-week position
60%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+275% holders QoQ · +12 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.31% of float · ▼ -32.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4
Now $23 · 60%
Range high $37
vs 200-day avg +34%
vs 50-day avg +31%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
APLM
this stock
Apollomics Inc.
|
$51.39M | +25.2% | — | — | 0.3% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
15
- % held
- 110.1%
- Net QoQ
- +2.4M sh
- Top holder
- HRT FINANCIAL LP
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Nov 25, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| APLM | +38.5% | +0.6% | +15.7% | +35.7% | +25.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +38.1% | -3.9% | +1.9% | +31.8% | +11.3% |
Key facts
CIK
1944885
CUSIP
G0411D123
13F (30d)
16 filings
16 filers
Visit website
Investor relations